If the clinical phenotype is not typical, either multi-gene panels (that include NF1, SPRED1 genes, or rasopathy multigene panel) or comprehensive genomic testing (as exome sequencing or genome sequencing) may be considered [23,24]. Here, SPRED1 is linked to RASopathy.